Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
0(0%)
Results Posted
70%(7 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
4
36%
Ph phase_3
5
45%

Phase Distribution

0

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
5(55.6%)
Phase 4Post-market surveillance
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(10)
Terminated(1)

Detailed Status

Completed10
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 35 (55.6%)
Phase 44 (44.4%)

Trials by Status

completed1091%
terminated19%

Recent Activity

0 active trials
Showing 5 of 11
completed

Antidiabetic Medications and Risk of Cancer

NCT07628556
completedphase_4

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

NCT02730377
completedphase_4

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

NCT01917656
completedphase_3

Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes

NCT00789191
completedphase_4

Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

NCT02027753
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07628556

Antidiabetic Medications and Risk of Cancer

Completed
NCT02730377Phase 4

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

Completed
NCT01917656Phase 4

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

Completed
NCT00789191Phase 3

Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes

Completed
NCT02027753Phase 4

Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

Completed
NCT01278485

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)

Completed
NCT01137812Phase 3

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Completed
NCT01381900Phase 3

A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

Completed
NCT00575588Phase 3

52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

Completed
NCT00766441Phase 4

Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan

Terminated
NCT00359112Phase 3

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11